Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 132

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 132
---
 Title
     
    Date

    /s/ Lloyd M. Segal
     
     President, Chief Executive Officer and Director(Principal Executive Officer)
     
    March 3, 2025

    Lloyd M. Segal

    /s/ Steve Forte
     
     Executive Vice President, Chief Financial  Officer(Principal Financial Officer and Principal Accounting Officer)
     
    March 3, 2025

    Steve Forte

    /s/ Thomas Civik
     
     Chair of the Board of Directors
     
    March 3, 2025 

    Thomas Civik

    /s/ David Bonita, M.D.
     
     Director
     
    March 3, 2025

    David Bonita, M.D.

    /s/ Samarth Kulkarni, Ph.D.
     
     Director
     
    March 3, 2025 

    Samarth Kulkarni, Ph.D.

    /s/ Susan M. Molineaux, Ph.D.
     
     Director
     
    March 3, 2025

    Susan M. Molineaux, Ph.D.

    /s/ Ann D. Rhoads
     
     Director
     
    March 3, 2025

    Ann D. Rhoads

    /s/ Carol A. Schafer
     
     Director
     
    March 3, 2025

    Carol A. Schafer

    /s/ Steven H. Stein, M.D.
     
     Director
     
    March 3, 2025

    Steven H. Stein

148